339 related articles for article (PubMed ID: 16570240)
21. Novel mutations of the tyrosinase (TYR) gene in type I oculocutaneous albinism (OCA1).
Spritz RA; Oh J; Fukai K; Holmes SA; Ho L; Chitayat D; France TD; Musarella MA; Orlow SJ; Schnur RE; Weleber RG; Levin AV
Hum Mutat; 1997; 10(2):171-4. PubMed ID: 9259202
[No Abstract] [Full Text] [Related]
22. Evaluation of denaturing high performance liquid chromatography for the mutational analysis of the MEN1 gene.
Crépin M; Pigny P; Escande F; Bauters CC; Calender A; Lefevre S; Buisine MP; Porchet N; Odou MF
J Mol Endocrinol; 2006 Apr; 36(2):369-76. PubMed ID: 16595707
[TBL] [Abstract][Full Text] [Related]
23. Tyrosinase gene analysis in Japanese patients with oculocutaneous albinism.
Goto M; Sato-Matsumura KC; Sawamura D; Yokota K; Nakamura H; Shimizu H
J Dermatol Sci; 2004 Sep; 35(3):215-20. PubMed ID: 15381243
[TBL] [Abstract][Full Text] [Related]
24. [An overview of oculocutaneous albinism: TYR gene mutations in five Colombian individuals].
Sanabria D; Groot H; Guzmán J; Lattig MC
Biomedica; 2012 Jun; 32(2):269-76. PubMed ID: 23242301
[TBL] [Abstract][Full Text] [Related]
25. Prenatal diagnosis of oculocutaneous albinism two mutations located at the same allele.
Hsieh YY; Wu JY; Chang CC; Tsai FJ; Lee CC; Tsai HD; Tsai CH
Prenat Diagn; 2001 Mar; 21(3):200-1. PubMed ID: 11260608
[TBL] [Abstract][Full Text] [Related]
26. Genetic analyses of oculocutaneous albinism types 1 and 2 with four novel mutations.
Yang Q; Yi S; Li M; Xie B; Luo J; Wang J; Rong X; Zhang Q; Qin Z; Hang L; Feng S; Fan X
BMC Med Genet; 2019 Jun; 20(1):106. PubMed ID: 31196117
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of denaturing high-performance liquid chromatography as a rapid detection method for identification of epidermal growth factor receptor mutations in nonsmall-cell lung cancer.
Cohen V; Agulnik JS; Jarry J; Batist G; Small D; Kreisman H; Tejada NA; Miller WH; Chong G
Cancer; 2006 Dec; 107(12):2858-65. PubMed ID: 17096434
[TBL] [Abstract][Full Text] [Related]
28. Mutations of the tyrosinase gene in three Korean patients with type I oculocutaneous albinism.
Park KC; Park SK; Lee YS; Youn SW; Park BS; Kim KH; Lee ST
Jpn J Hum Genet; 1996 Sep; 41(3):299-305. PubMed ID: 8996965
[TBL] [Abstract][Full Text] [Related]
29. [Oculocutaneous albinism in French overseas territories (Reunion, French Guyana, Martinique) and Mayotte. Study of 21 cases in 16 families].
Aquaron R; Berge-Lefranc JL; Badens C; Roche J; Fite A; Sainte-Marie D; Piquion N; Cartault F
Med Trop (Mars); 2005 Nov; 65(6):584-91. PubMed ID: 16555521
[TBL] [Abstract][Full Text] [Related]
30. Reliability of DHPLC in mutational screening of beta-globin (HBB) alleles.
Colosimo A; Guida V; De Luca A; Cappabianca MP; Bianco I; Palka G; Dallapiccola B
Hum Mutat; 2002 Mar; 19(3):287-95. PubMed ID: 11857746
[TBL] [Abstract][Full Text] [Related]
31. Identification of TYR mutations in patients with oculocutaneous albinism.
Sun W; Shen Y; Shan S; Han L; Li Y; Zhou Z; Zhong Z; Chen J
Mol Med Rep; 2018 Jun; 17(6):8409-8413. PubMed ID: 29658579
[TBL] [Abstract][Full Text] [Related]
32. Mutational Analysis of the TYR and OCA2 Genes in Four Chinese Families with Oculocutaneous Albinism.
Wang Y; Wang Z; Chen M; Fan N; Yang J; Liu L; Wang Y; Liu X
PLoS One; 2015; 10(4):e0125651. PubMed ID: 25919014
[TBL] [Abstract][Full Text] [Related]
33. Polymorphic sequences of the tyrosinase gene: allele analysis on 16 OCA1 patients in Japan indicate that three polymorphic sequences in the tyrosinase gene promoter could be powerful markers for indirect gene diagnosis.
Tanita M; Matsunaga J; Miyamura Y; Dakeishi M; Nakamura E; Kono M; Shimizu H; Tagami H; Tomita Y
J Hum Genet; 2002; 47(1):1-6. PubMed ID: 11829136
[TBL] [Abstract][Full Text] [Related]
34. Mutational Analysis of TYR, OCA2, and SLC45A2 Genes in Chinese Families with Oculocutaneous Albinism.
Lin Y; Chen X; Yang Y; Che F; Zhang S; Yuan L; Wu Y
Mol Genet Genomic Med; 2019 Jul; 7(7):e00687. PubMed ID: 31199599
[TBL] [Abstract][Full Text] [Related]
35. Tyrosinase and ocular diseases: some novel thoughts on the molecular basis of oculocutaneous albinism type 1.
Ray K; Chaki M; Sengupta M
Prog Retin Eye Res; 2007 Jul; 26(4):323-58. PubMed ID: 17355913
[TBL] [Abstract][Full Text] [Related]
36. Identification of a missense mutation in the tyrosinase gene in a Chinese family with oculocutaneous albinism type 1.
Lu Q; Yuan L; Xu H; Huang X; Yang Z; Yi J; Ni B; Chen Y; Deng H
Mol Med Rep; 2017 Mar; 15(3):1426-1430. PubMed ID: 28112372
[TBL] [Abstract][Full Text] [Related]
37. Tumour necrosis factor receptor superfamily member 6 gene mutation detection by denaturing high-performance liquid chromatography.
Etokebe GE; Abrahamsen TG; Bogen B; Spurkland A
Scand J Immunol; 2004 May; 59(5):496-503. PubMed ID: 15140060
[TBL] [Abstract][Full Text] [Related]
38. Mutation analysis of a Chinese family with oculocutaneous albinism.
Wang X; Zhu Y; Shen N; Peng J; Wang C; Liu H; Lu Y
Oncotarget; 2016 Dec; 7(51):84981-84988. PubMed ID: 27829221
[TBL] [Abstract][Full Text] [Related]
39. Non-random distribution of missense mutations within the human tyrosinase gene in type I (tyrosinase-related) oculocutaneous albinism.
King RA; Mentink MM; Oetting WS
Mol Biol Med; 1991 Feb; 8(1):19-29. PubMed ID: 1943686
[TBL] [Abstract][Full Text] [Related]
40. [Prenatal diagnosis of oculocutaneous albinism type IV and discovery of a novel mutation].
Pang T; Lei J; Zheng H; Xu B; Jiang WY; Li HY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Feb; 28(1):1-5. PubMed ID: 21287499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
